Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Talcott

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2002
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studiesRonald Feld, Marianne Paesmans, Alison G Freifeld, et al.
Cancer|September 18, 2008
Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes studyPamela Spain, William R Carpenter, James A Talcott, et al.
Cancer Causes & Control : CCC|September 25, 2009
Race, healthcare access and physician trust among prostate cancer patientsYoung Kyung Do, William R Carpenter, Pamela Spain, et al.
Cancer Medicine|June 1, 2017
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decadeJoanne W Jang, Michael R Drumm, Jason A Efstathiou, et al.
Cancer|March 14, 2007
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experienceJames A Talcott, Pamela Spain, Jack A Clark, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trialPaul L Nguyen, Ronald C Chen, Karen E Hoffman, et al.
Evaluation & the Health Professions|April 27, 2005
Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancerDavid T Eton, Jin-Shei Lai, David Cella, et al.
Cancer Causes & Control : CCC|June 20, 2006
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States)Jacob H Cohen, Victor J Schoenbach, Jay S Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Time course and predictors of symptoms after primary prostate cancer therapyJames A Talcott, Judithy Manola, Jack A Clark, et al.
Cancer|July 29, 2009
Racial differences in trust and regular source of patient care and the implications for prostate cancer screening useWilliam R Carpenter, Paul A Godley, Jack A Clark, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2002
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studiesRonald Feld, Marianne Paesmans, Alison G Freifeld, et al.
Cancer|September 18, 2008
Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes studyPamela Spain, William R Carpenter, James A Talcott, et al.
Cancer Causes & Control : CCC|September 25, 2009
Race, healthcare access and physician trust among prostate cancer patientsYoung Kyung Do, William R Carpenter, Pamela Spain, et al.
Cancer Medicine|June 1, 2017
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decadeJoanne W Jang, Michael R Drumm, Jason A Efstathiou, et al.
Cancer|March 14, 2007
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experienceJames A Talcott, Pamela Spain, Jack A Clark, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trialPaul L Nguyen, Ronald C Chen, Karen E Hoffman, et al.
Evaluation & the Health Professions|April 27, 2005
Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancerDavid T Eton, Jin-Shei Lai, David Cella, et al.
Cancer Causes & Control : CCC|June 20, 2006
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States)Jacob H Cohen, Victor J Schoenbach, Jay S Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Time course and predictors of symptoms after primary prostate cancer therapyJames A Talcott, Judithy Manola, Jack A Clark, et al.
Cancer|July 29, 2009
Racial differences in trust and regular source of patient care and the implications for prostate cancer screening useWilliam R Carpenter, Paul A Godley, Jack A Clark, et al.
Pageof 6